Literature DB >> 27861798

Characterizing polyubiquitinated forms of the neurodegenerative ubiquitin mutant UBB+1.

Michal Chojnacki1, Daoning Zhang2, Monika Talarowska3, Piotr Gałecki3, Janusz Szemraj1, David Fushman2, Mark A Nakasone2.   

Abstract

The ubiquitin mutant UBB+1 has been identified as a hallmark of neurodegenerative diseases. In this study, we characterize polyubiquitinated forms of UBB+1 in vitro and from patient samples. The ability of UBB+1 to be readily ubiquitinated by several E2 enzymes provided a mechanism for the controlled synthesis and purification of defined conjugates. This allowed us to utilize polyUb-UBB+1 conjugates for biochemical assays, as well as solution NMR. Coupled with our immunoassay for detection of ubiquitinated forms of UBB+1 in patient blood samples, we gain a clearer picture of the molecular mechanisms underlying neurodegenerative diseases.
© 2016 Federation of European Biochemical Societies.

Entities:  

Keywords:  zzm321990UBBzzm321990+1zzm321990; biomolecular NMR; deubiquitinase; neurodegeneration; polyubiquitin

Mesh:

Substances:

Year:  2016        PMID: 27861798      PMCID: PMC5182158          DOI: 10.1002/1873-3468.12484

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  39 in total

1.  Structural properties of polyubiquitin chains in solution.

Authors:  Ranjani Varadan; Olivier Walker; Cecile Pickart; David Fushman
Journal:  J Mol Biol       Date:  2002-12-06       Impact factor: 5.469

2.  Mutant ubiquitin UBB+1 is accumulated in sporadic inclusion-body myositis muscle fibers.

Authors:  P Fratta; W K Engel; F W Van Leeuwen; E M Hol; G Vattemi; V Askanas
Journal:  Neurology       Date:  2004-09-28       Impact factor: 9.910

3.  Dose-dependent inhibition of proteasome activity by a mutant ubiquitin associated with neurodegenerative disease.

Authors:  Paula van Tijn; Femke M S de Vrij; Karianne G Schuurman; Nico P Dantuma; David F Fischer; Fred W van Leeuwen; Elly M Hol
Journal:  J Cell Sci       Date:  2007-04-03       Impact factor: 5.285

4.  Structural basis of E2-25K/UBB+1 interaction leading to proteasome inhibition and neurotoxicity.

Authors:  Sunggeon Ko; Gil Bu Kang; Sung Min Song; Jung-Gyu Lee; Dong Yeon Shin; Ji-Hye Yun; Yi Sheng; Chaejoon Cheong; Young Ho Jeon; Yong-Keun Jung; Cheryl H Arrowsmith; George V Avvakumov; Sirano Dhe-Paganon; Yung Joon Yoo; Soo Hyun Eom; Weontae Lee
Journal:  J Biol Chem       Date:  2010-09-08       Impact factor: 5.157

5.  Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases.

Authors:  Remko de Pril; David F Fischer; Marion L C Maat-Schieman; Barbara Hobo; Rob A I de Vos; Ewout R Brunt; Elly M Hol; Raymund A C Roos; Fred W van Leeuwen
Journal:  Hum Mol Genet       Date:  2004-06-15       Impact factor: 6.150

6.  Labeling of a protein with fluorophores using maleimide derivitization.

Authors:  Jagpreet S Nanda; Jon R Lorsch
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

7.  Mutant ubiquitin decreases amyloid β plaque formation in a transgenic mouse model of Alzheimer's disease.

Authors:  Paula van Tijn; Frank J A Dennissen; Romina J G Gentier; Barbara Hobo; Denise Hermes; Harry W M Steinbusch; Fred W Van Leeuwen; David F Fischer
Journal:  Neurochem Int       Date:  2012-07-14       Impact factor: 3.921

8.  The structure and conformation of Lys63-linked tetraubiquitin.

Authors:  Ajit B Datta; Greg L Hura; Cynthia Wolberger
Journal:  J Mol Biol       Date:  2009-08-04       Impact factor: 5.469

9.  The EHEC type III effector NleL is an E3 ubiquitin ligase that modulates pedestal formation.

Authors:  Heather Piscatelli; Shalaka A Kotkar; Megan E McBee; Sureshkumar Muthupalani; David B Schauer; Robert E Mandrell; John M Leong; Daoguo Zhou
Journal:  PLoS One       Date:  2011-04-26       Impact factor: 3.240

10.  Ubiquitin chain conformation regulates recognition and activity of interacting proteins.

Authors:  Yu Ye; Georg Blaser; Mathew H Horrocks; Maria J Ruedas-Rama; Shehu Ibrahim; Alexander A Zhukov; Angel Orte; David Klenerman; Sophie E Jackson; David Komander
Journal:  Nature       Date:  2012-12-02       Impact factor: 49.962

View more
  2 in total

Review 1.  USP2-Related Cellular Signaling and Consequent Pathophysiological Outcomes.

Authors:  Hiroshi Kitamura; Mayuko Hashimoto
Journal:  Int J Mol Sci       Date:  2021-01-26       Impact factor: 5.923

Review 2.  The Dose-Dependent Pleiotropic Effects of the UBB+1 Ubiquitin Mutant.

Authors:  Katarzyna Banasiak; Natalia A Szulc; Wojciech Pokrzywa
Journal:  Front Mol Biosci       Date:  2021-03-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.